Lycosin-II

General Information


DCTPep ID  DCTPep01121

Peptide Name   Lycosin-II

Sequence  VWLSALKFIGKHLAKHQLSKL

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

ACP Tumor active peptide



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
HCT 116 Colon carcinoma IC50=70.79 µg/mL MTT assay 24h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  IC50 on PBMCs was = 92.0 ± 39.6 μM

Target  Not available

Affinity  Not available

Mechanism  Lycosin-II Suppresses the Growth of Tumor Cells and Kills them Through Membrane Disruption and Apoptosis Induction



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep01121

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C116H189N31O25

Absent amino acids  CDEMNPRTY

Theoretical pI  10.48

Acidic residues  0

Basic residues  6

Polar residues  3

Molecular weight (Average)  2417.97

Molecular weight (Monoisotopic)  2416.45

Common amino acids  L

Net charge  6

Instability index (II)  3.27

Aliphatic index  134.76

Grand average of hydropathicity (GRAVY)  0.271

Half Life 
  100 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 5500
  Abs 0.1% (=1 g/l) 2.275

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Lycosin-II Suppresses the Growth of Tumor Cells and Kills them Through Membrane Disruption and Apoptosis Induction

Doi 10.1007/s10989-018-9736-3

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.